[Robert: paste actual Google Review quote — topic-filtered for this page]
Authentic Saxenda from Novo Nordisk — FDA-approved Liraglutide for chronic weight management. Daily subcutaneous injection. Cold-chain delivery across Thailand.

That's −6.8 kg — you'd weigh .
Based on the 8.0% trial-mean. Individual outcomes vary.



Licensed medical facility · Real photos · Dr. Kenika
Saxenda is FDA-approved for chronic weight management in adults with obesity (BMI ≥30) or overweight (BMI ≥27) plus comorbidities. The molecule — Liraglutide — is a GLP-1 receptor agonist administered as a once-daily subcutaneous injection (in contrast to the weekly newer-generation drugs Wegovy and Ozempic). Saxenda was the first GLP-1 approved for obesity (December 2014) and remains an option for patients who prefer daily routines or have specific tolerability profiles.
GLP-1 receptor agonist. Single-pathway mechanism similar to Semaglutide but with shorter half-life requiring daily dosing. Established safety profile since 2014.
Read more about the molecule on our Liraglutide Thailand page.
Saxenda: Obesity indication (December 2014). Wegovy: Weekly injection · stronger weight loss. Both contain Liraglutide manufactured by Novo Nordisk. Dr. Kenika selects based on clinical situation.
See Wegovy Thailand.
Doctor-led · Authentic Novo Nordisk · Daily Liraglutide
Daily injection · same pen across all dose levels (0.6 → 3 mg titration)
Saxenda (liraglutide) was the first FDA-approved GLP-1 for chronic weight management (2014). Daily injection, gradual five-week titration to 3 mg maintenance. Prescribed on patient request — most patients today choose the weekly options (Mounjaro or Wegovy) for stronger efficacy.
Trajectory based on the SCALE Obesity clinical-trial mean. Your individualized program is confirmed in consultation — this is an evidence-based estimate, not a guarantee.
Your trajectory · based on SCALE Obesity mean (Saxenda)
Estimator uses peer-reviewed clinical-trial mean data. Individual outcomes vary based on adherence, baseline BMI, comorbidities, and lifestyle factors. Final program plan determined in private medical consultation.[ref]
Saxenda follows the Novo Nordisk prescribing-information titration. Incremental dose increases minimize GI side effects.
Source: Novo Nordisk Saxenda prescribing information. Adapted individually by Dr. Kenika.
15-minute WhatsApp with our clinic team. Share your goals, history, and questions. No commitment.
Dr. Kenika reviews your history. Labs ordered if needed. Treatment plan decided based on your specific clinical picture.
First dose at clinic or cold-chain delivery to your address. Titration plan + side-effect support from day one.
Weekly check-ins during titration. Dose adjusted to your response. Sustainable maintenance plan together.
Every Saxenda patient is personally supervised by Dr. Kenika — medical history review, HbA1c monitoring where relevant, dose decisions, titration adjustments. No intake-form-only approval.
Authentic Saxenda from Novo Nordisk via cold-chain pharmacy distribution. Batch numbers and expiry dates intact. No compounded substitutes, no grey-market sourcing.
In-clinic in Pattaya, concierge nurse to your hotel in Bangkok, or online consultation with cold-chain delivery in Phuket and beyond.
Real reviews from real patients on Google Business Profile. Currently 5.0 ★ from 15 verified reviews — and growing.
[Robert: paste actual Google Review quote — topic-filtered for this page]
[Robert: paste actual Google Review quote — topic-filtered for this page]
[Robert: paste actual Google Review quote — topic-filtered for this page]
Request a consultation. Our clinic team responds within minutes on WhatsApp.
Request consultation
Peer-reviewed primary sources, FDA prescribing information, manufacturer documentation.
Additional clinical questions discussed during your private consultation with Dr. Kenika.